Screener
Amneal Pharmaceuticals, Inc. AMRX Government label — Net revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total Specialty net revenue | 149,295 | 128,043 | 282,560 | 236,340 |
| AvKARE | ||||
| Distribution | 86,930 | 99,663 | 176,079 | 204,558 |
| Government label | 50,207 | 45,418 | 110,156 | 95,558 |
| Institutional | 12,112 | 10,132 | 21,931 | 21,141 |
| Other | 7,740 | 7,827 | 14,840 | 14,198 |
| Total AvKARE net revenue | 156,989 | 163,040 | 323,006 | 335,455 |
| Total net revenue | $796,197 | $724,508 | $1,518,716 | $1,419,928 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s government label — net revenue?
- Amneal Pharmaceuticals, Inc. (AMRX) reported government label — net revenue of $50.21M in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s government label — net revenue changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s government label — net revenue increased by 10.5% year-over-year, from $45.42M to $50.21M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s government label — net revenue?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s government label — net revenue has grown at a 22.9% compound annual growth rate (CAGR), from $118.38M to $270.11M.
- What does government label — net revenue mean?
- This metric represents the total net revenue generated from the sale of pharmaceutical products specifically categorized under government-labeled or government-contracted programs. It reflects the company's ability to secure and fulfill supply agreements with public sector entities, which often serve as a stable, high-volume revenue stream. Monitoring this figure helps investors assess the company's exposure to public healthcare procurement and the competitive positioning of its portfolio within government-regulated markets.
Ask your AI about Amneal Pharmaceuticals, Inc.'s government label — net revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude